NovoCure NVCR
NASDAQ NVCR
$15.95 -0.04 (-0.25%)
At close: Sep 30, 2026 · 4:00 PM EDT

NovoCure (NVCR) Notes Payables (2024 - 2025)

Updated

NovoCure's Notes Payables was $560.62 million in Q3 2025, up 0.6% from $557.33 million a year earlier and up 0.1% from the prior quarter.

Analysis

NovoCure (NVCR) Notes Payables (2024 - 2025) Analysis & Trends

At the end of FY2024, Notes Payables at NovoCure came in at $558.16 million.

  • Per Business Quant data, NVCR's Notes Payables in the three quarters before Q3 2025 was $559.79 million (Q2 2025), $558.97 million (Q1 2025) and $558.16 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 NovoCure 1.86 Bn -491.82 Mn 142.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 560.62 Mn
Jun 30, 2025 559.79 Mn
Mar 31, 2025 558.97 Mn
Dec 31, 2024 558.16 Mn
Sep 30, 2024 557.33 Mn
API Access

NovoCure Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=NVCR&period=max&api_key=YOUR_API_KEY